4.7 Article

Anion inhibition studies of the α-carbonic anhydrase from the protozoan pathogen Trypanosoma cruzi, the causative agent of Chagas disease

期刊

BIOORGANIC & MEDICINAL CHEMISTRY
卷 21, 期 15, 页码 4472-4476

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2013.05.058

关键词

Carbonic anhydrase; Anion; Alpha-class enzyme; Inhibitor; Trypanosoma cruzi

资金

  1. FP7 EU project (Metoxia)
  2. Academy of Finland
  3. Sigrid Juselius Foundation
  4. Competitive Research Funding of Tampere University Hospital [9N054]
  5. Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES)
  6. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (MCT/CNPq)
  7. Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)

向作者/读者索取更多资源

The protozoan pathogen Trypanosoma cruzi, the causative agent of Chagas disease, encodes an alpha-class carbonic anhydrase (CA, EC 4.2.1.1), TcCA, which was recently shown to be crucial for its life cycle. Thiols, a class of strong TcCA inhibitors, were also shown to block the growth of the pathogen in vitro. Here we report the inhibition of TcCA by inorganic and complex anions and other molecules interacting with zinc proteins, such as sulfamide, sulfamic acid, phenylboronic/arsonic acids. TcCA was inhibited in the low micromolar range by iodide, cyanate, thiocyanate, hydrogensulfide and trithiocarbonate (K(I)s in the range of 44-93 mu M), but the best inhibitor was diethyldithiocarbamate (K-I = 5 mu M). Sulfamide showed an inhibition constant of 120 mu M, but sulfamic acid was much less effective (K-I of 10.6 mM). The discovery of diethyldithiocarbamate as a low micromolar TcCA inhibitor may be useful to detect leads for developing anti-Trypanosoma agents with a diverse mechanism of action compared to clinically used drugs (benznidazole, nifurtimox) for which significant resistance emerged. (C) 2013 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据